LEQEMBI(R) Pen (Subcutaneous Formulation of LEQEMBI(R)) Now Available in Japan for Patients with Early Alzheimer’s Disease

No
Redakcija
-
LEQEMBI(R) Pen (Subcutaneous Formulation of LEQEMBI(R)) Now Available in Japan for Patients with Early Alzheimer’s Disease

TOKYO and CAMBRIDGE, Mass., November 13, 2026 – (JCN Newswire) – Eisai Co., Ltd. and Biogen Inc. (Nasdaq: BIIB) announced today that “LEQEMBI® Pen”, the subcutaneous (SC) formulation of “LEQEMBI®” (generic name: lecanemab) has been launched in Japan.LEQEMBI Pen was approved as a new route of administration in Japan on September 16…
Read More

Zaļā Josta - Reklāma